Signals, Powered By EquityPandit
On Tuesday, the drug major Lupin said that its Board of Directors have given the approval for raising funds up to Rs 7,500 crore.
In a BSE filing the company said, “The Board of Directors at their meeting held on June 22, 2015, approved in principle the raising of funds up to Rs 75,000 million through issue of Securities i.e., equity shares, GDRs, ADRs, convertible bonds, equity linked instruments, etc. as may be appropriate.”
It also added that the enabling approval of the shareholders to the above will be sought at the Annual General Meeting scheduled for July 23, 2015.
